https://www.selleckchem.com/pr....oducts/apr-246-prima
Median survival was 18 months. One- and 2-year survival rates were 56% and 44%, respectively. Conclusions tMF often expresses CD30 and presents with lymph node involvement. Responses have been seen with single agents, but survival remains poor. Novel treatment approaches are urgently needed to improve outcomes.Background The premalignant nature of ampullary adenomas justifies their radical excision. Aims Aim of this study is to evaluate the long-term results of endoscopic snare papillectomy in a consecutive series of patients